Clinical trial / 2017
Lutein and zeaxanthin supplementation improved MPOD and aspects of cognitive function in community-dwelling older adults.
A total of 62 community-dwelling older adults were randomized to receive 12 mg of lutein and zeaxanthin (L+Z) or a placebo, with data from 51 participants analyzed. Participants receiving L+Z had significant increases in MPOD (p < 0.03) and improvements in complex attention (p < 0.02) and cognitive flexibility (p < 0.04) compared to placebo. A trend was observed for executive function (p = 0.073), and composite memory improved specifically among male participants (p = 0.04).
- Study type
- Double-masked, randomized, placebo-controlled trial
- Who was studied
- 62 older adults randomized (51 analyzed, mean age 73.7 years)
- What was measured
- Macular pigment optical density (MPOD) and cognitive function
THE PAPER
Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial.
Hammond BR, Miller LS, Bello MO, Lindbergh CA, Mewborn C, Renzi-Hammond LM. Front Aging Neurosci, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.